Enhancing the circulating half-life of antibody-based fusion proteins

Details for Australian Patent Application No. 2001243148 (hide)

Owner Merck Patent GmbH

Inventors Lo, Kin Ming; Burger, Christa; Gillies, Stephen D.

Agent Davies Collison Cave

Pub. Number AU-B-2001243148

PCT Pub. Number WO01/58957

Priority 60181768 11.02.00 US

Filing date 9 February 2001

Wipo publication date 20 August 2001

Acceptance publication date 23 March 2006

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

11 December 2003 Assignment before Grant

  Lexigen Pharmaceuticals Corp The application has been assigned to Merck Patent GmbH

23 March 2006 Application Accepted

  Published as AU-B-2001243148

20 July 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001243149

2001243147